Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intra-Cellular Ther
(NQ:
ITCI
)
74.94
-0.55 (-0.72%)
Streaming Delayed Price
Updated: 9:35 AM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
21,609
Open
75.23
Bid (Size)
74.73 (1)
Ask (Size)
75.14 (4)
Prev. Close
75.48
Today's Range
74.73 - 75.51
52wk Range
45.50 - 84.89
Shares Outstanding
94,324,313
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
June 18, 2024
Via
Benzinga
Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study
June 18, 2024
Intra-Cellular Therapies reports positive topline results for Study 502 on lumateperone 42 mg as adjunctive therapy for major depressive disorder. FDA application expected in H2 2024.
Via
Benzinga
Exposures
Product Safety
Performance
YTD
+6.31%
+6.31%
1 Month
+14.72%
+14.72%
3 Month
+11.49%
+11.49%
6 Month
+14.79%
+14.79%
1 Year
+14.44%
+14.44%
More News
Read More
Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win
June 18, 2024
Via
Investor's Business Daily
Where Intra-Cellular Therapies Stands With Analysts
June 12, 2024
Via
Benzinga
The Secret Stock Stash: 3 Overlooked Picks That Belong in Every Portfolio
May 30, 2024
Via
InvestorPlace
Analyst Ratings For Intra-Cellular Therapies
May 08, 2024
Via
Benzinga
The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts
April 22, 2024
Via
Benzinga
How Is The Market Feeling About Intra-Cellular Therapies?
April 19, 2024
Via
Benzinga
ITCI Stock Earnings: Intra-Cellular Therapies Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
Via
InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
April 19, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
April 17, 2024
Via
Benzinga
8 Analysts Assess Intra-Cellular Therapies: What You Need To Know
April 03, 2024
Via
Benzinga
Where Intra-Cellular Therapies Stands With Analysts
February 23, 2024
Via
Benzinga
Analyst Scoreboard: 8 Ratings For Intra-Cellular Therapies
January 18, 2024
Via
Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Intra-Cellular Therapies
January 02, 2024
Via
Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 16, 2024
Via
Benzinga
Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study
April 16, 2024
Via
Benzinga
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
April 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intra-Cellular Therapies Inc. (NASDAQ: ITCI) Climbs to New 52-Week High
April 16, 2024
Via
Investor Brand Network
Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results
April 16, 2024
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 16, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition
February 21, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.